GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » AstraZeneca PLC (XSWX:AZN) » Definitions » Shiller PE Ratio

AstraZeneca (XSWX:AZN) Shiller PE Ratio : (As of May. 27, 2024)


View and export this data going back to 2014. Start your Free Trial

What is AstraZeneca Shiller PE Ratio?

Note: If the price history is too short, we do not calculate current Shiller PE for this stock. All the historical data is shown as the company's primary share's data instead.

Shiller PE for Stocks: The True Measure of Stock Valuation


AstraZeneca Shiller PE Ratio Historical Data

The historical data trend for AstraZeneca's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AstraZeneca Shiller PE Ratio Chart

AstraZeneca Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 32.82 35.15 52.72 71.22 59.70

AstraZeneca Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 69.34 66.74 65.79 59.70 57.14

Competitive Comparison of AstraZeneca's Shiller PE Ratio

For the Drug Manufacturers - General subindustry, AstraZeneca's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


AstraZeneca's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, AstraZeneca's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where AstraZeneca's Shiller PE Ratio falls into.



AstraZeneca Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

AstraZeneca's E10 for the quarter that ended in Mar. 2024 is calculated as:

For example, AstraZeneca's adjusted earnings per share data for the three months ended in Mar. 2024 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=0/131.6000*131.6000
=0.000

Current CPI (Mar. 2024) = 131.6000.

AstraZeneca Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201406 0.564 99.800 0.744
201409 0.187 100.000 0.246
201412 -0.244 99.900 -0.321
201503 0.431 99.600 0.569
201506 0.513 100.100 0.674
201509 0.583 100.200 0.766
201512 0.627 100.400 0.822
201603 0.500 100.400 0.655
201606 -0.002 101.000 -0.003
201609 0.779 101.500 1.010
201612 1.478 102.200 1.903
201703 0.421 102.700 0.539
201706 0.368 103.500 0.468
201709 0.520 104.300 0.656
201712 1.017 105.000 1.275
201803 0.256 105.100 0.321
201806 0.267 105.900 0.332
201809 0.329 106.600 0.406
201812 0.813 107.100 0.999
201903 0.470 107.000 0.578
201906 0.089 107.900 0.109
201909 0.228 108.400 0.277
201912 0.236 108.500 0.286
202003 0.566 108.600 0.686
202006 0.552 108.800 0.668
202009 0.448 109.200 0.540
202012 0.693 109.400 0.834
202103 1.097 109.700 1.316
202106 0.381 111.400 0.450
202109 -1.015 112.400 -1.188
202112 -0.203 114.700 -0.233
202203 0.232 116.500 0.262
202206 0.223 120.500 0.244
202209 1.022 122.300 1.100
202212 0.540 125.300 0.567
202303 0.000 126.800 0.000
202306 0.000 129.400 0.000
202309 0.000 130.100 0.000
202312 0.000 130.500 0.000
202403 0.000 131.600 0.000

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


AstraZeneca  (XSWX:AZN) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


AstraZeneca Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of AstraZeneca's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


AstraZeneca (XSWX:AZN) Business Description

Address
1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge, GBR, CB2 0AA
A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across several major therapeutic classes, including gastrointestinal, diabetes, cardiovascular, respiratory, cancer, immunology and rare diseases. The majority of sales come from international markets with the United States representing close to one third of its revenue.

AstraZeneca (XSWX:AZN) Headlines

From GuruFocus

AstraZeneca: Growth Is Still a Better Choice

By Nathan Aisenstadt 11-15-2023